Skip to main content
Erschienen in: Endocrine 1/2019

18.04.2019 | Original Article

Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study

verfasst von: Yuanchi Hui, Jinping Wang, Yali An, Qiuhong Gong, Hui Li, Bo Zhang, Ying Shuai, Yanyan Chen, Yinghua Hu, Guangwei Li

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to investigate premature mortality and the risk of cardiovascular disease (CVD) in Chinese adults with diabetes diagnosed before the age of 45 years.

Methods

A total of 519 participants with normal glucose tolerance (NGT) and 630 with newly diagnosed diabetes mellitus (DM) were recruited in 1986 in the Da Qing Diabetes Study. In 2009, the participants were followed up to assess mortality and CVD events. The subjects were stratified into four subgroups according to age and diabetes status: age <45 years with NGT (NGT<45y), age <45 years with DM (DM<45y), age ≥45 years with NGT (NGT≥45y), and age ≥45 years with DM (DM≥45y). The risk of death and CVD events in patients with young-onset DM and elder subjects with NGT were compared to show the extent of premature death and CVD in the DM participants.

Results

During the 23-year follow-up, 26 (10.40%) participants in NGT<45y, 72 (34.12%) in DM<45y, 74 (30.58%) in NGT≥45y, and 266 (68.73%) in DM≥45y died, including 13 (5.20%), 36 (17.06%), 24 (9.92%), and 128 (33.07%) death attributed to CVD. The corresponding rates of CVD events were 56 (22.40%), 90 (42.65%), 89 (36.78), and 213 (55.04%). It also showed that the risk of all-cause death (HR 1.23, 95% CI 0.88–1.71) or CVD events (HR 1.25, 95% CI 0.93–1.69) did not differ significantly between the DM<45y and NGT≥45y groups after adjusting for sex, smoking, body mass index, systolic blood pressure, total cholesterol and previous history of CVD. Of note, participants in the DM<45y group had an higher risk of CVD mortality compared with that in the NGT≥45y group (HR 1.76, 95% CI 1.04–2.98), although the mean age in the former group was 12 years lesser than that in the latter group (39.01 ± 5.00 vs 51.45 ± 5.14).

Conclusions

Young-onset diabetes is a risk factor for the premature death and cardiovascular disease. Early prevention and intensive treatment are warrented in patients with young-onset diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
3.
Zurück zum Zitat J. Yang, J. Lu, J. Weng et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 362(12), 1090–1101 (2010)CrossRefPubMed J. Yang, J. Lu, J. Weng et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 362(12), 1090–1101 (2010)CrossRefPubMed
4.
Zurück zum Zitat J.J. Chamberlain, A.S. Rhinehart, C.F. Shaefer Jr., A. Neuman. Diagnosis and management of diabetes: synopsis of the 2016 american diabetes association standards of medical care in diabetes. Ann. Intern. Med. 164, 542–552 (2016)CrossRefPubMed J.J. Chamberlain, A.S. Rhinehart, C.F. Shaefer Jr., A. Neuman. Diagnosis and management of diabetes: synopsis of the 2016 american diabetes association standards of medical care in diabetes. Ann. Intern. Med. 164, 542–552 (2016)CrossRefPubMed
5.
Zurück zum Zitat A. Amutha, R.M. Anjana, U. Venkatesan et al. Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study). Diabetes Res. Clin. Pract. 123, 1–8 (2017)CrossRefPubMed A. Amutha, R.M. Anjana, U. Venkatesan et al. Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study). Diabetes Res. Clin. Pract. 123, 1–8 (2017)CrossRefPubMed
6.
Zurück zum Zitat T.A. Hillier, K.L. Pedula. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26, 2999–3005 (2003)CrossRefPubMed T.A. Hillier, K.L. Pedula. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26, 2999–3005 (2003)CrossRefPubMed
7.
Zurück zum Zitat S. Rao Kondapally Seshasai, S. Kaptoge, A. Thompson et al.Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364, 829–841 (2011)CrossRefPubMedPubMedCentral S. Rao Kondapally Seshasai, S. Kaptoge, A. Thompson et al.Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364, 829–841 (2011)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat D. Aune, S. Schlesinger, T. Norat, E. Riboli. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutr. Metab. Cardiovasc. Dis. 28, 543–556 (2018)CrossRefPubMed D. Aune, S. Schlesinger, T. Norat, E. Riboli. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutr. Metab. Cardiovasc. Dis. 28, 543–556 (2018)CrossRefPubMed
9.
Zurück zum Zitat E.T. Rhodes, L.A. Prosser, T.J. Hoerger, T. Lieu, D.S. Ludwig, L.M. Laffel. Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet. Med.: a J. Br. Diabet. Assoc. 29, 453–463 (2012)CrossRef E.T. Rhodes, L.A. Prosser, T.J. Hoerger, T. Lieu, D.S. Ludwig, L.M. Laffel. Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet. Med.: a J. Br. Diabet. Assoc. 29, 453–463 (2012)CrossRef
10.
Zurück zum Zitat X.R. Pan, G.W. Li, Y.H. Hu et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537–544 (1997)CrossRefPubMed X.R. Pan, G.W. Li, Y.H. Hu et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537–544 (1997)CrossRefPubMed
11.
Zurück zum Zitat X.R. Pan, Y.H. Hu, G.W. Li, P.A. Liu, P.H. Bennett, B.V. Howard. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study. Diabetes Care 16, 150–156 (1993)CrossRefPubMed X.R. Pan, Y.H. Hu, G.W. Li, P.A. Liu, P.H. Bennett, B.V. Howard. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study. Diabetes Care 16, 150–156 (1993)CrossRefPubMed
12.
Zurück zum Zitat Q. Gong, E.W. Gregg, J. Wang et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54, 300–307 (2011)CrossRefPubMed Q. Gong, E.W. Gregg, J. Wang et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54, 300–307 (2011)CrossRefPubMed
13.
Zurück zum Zitat G. Li, P. Zhang, J. Wang, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2, 474–480 (2014).CrossRefPubMed G. Li, P. Zhang, J. Wang, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2, 474–480 (2014).CrossRefPubMed
14.
Zurück zum Zitat C.E. Hambling, S.I. Seidu, M.J. Davies, K. Khunti. Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet. Med.: a J. Br. Diabet. Assoc. 34, 1219–1227 (2017)CrossRef C.E. Hambling, S.I. Seidu, M.J. Davies, K. Khunti. Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet. Med.: a J. Br. Diabet. Assoc. 34, 1219–1227 (2017)CrossRef
15.
Zurück zum Zitat G. Alberti, P. Zimmet, J. Shaw et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 27, 1798–1811 (2004)CrossRefPubMed G. Alberti, P. Zimmet, J. Shaw et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 27, 1798–1811 (2004)CrossRefPubMed
16.
Zurück zum Zitat V. Bansal, B.O. Boehm, A. Darvasi. Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals. Diabetologia 61, 2180–2188 (2018)CrossRefPubMed V. Bansal, B.O. Boehm, A. Darvasi. Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals. Diabetologia 61, 2180–2188 (2018)CrossRefPubMed
17.
Zurück zum Zitat R.C.W. Ma. Epidemiology of diabetes and diabetic complications in China. Diabetologia 61, 1249–1260 (2018)CrossRefPubMed R.C.W. Ma. Epidemiology of diabetes and diabetic complications in China. Diabetologia 61, 1249–1260 (2018)CrossRefPubMed
18.
Zurück zum Zitat E. Chow, J.C. Chan. Explaining the high prevalence of young-onset diabetes among Asians and Indigenous Australians. Med. J. Aust. 207, 331–332 (2017)CrossRefPubMed E. Chow, J.C. Chan. Explaining the high prevalence of young-onset diabetes among Asians and Indigenous Australians. Med. J. Aust. 207, 331–332 (2017)CrossRefPubMed
19.
Zurück zum Zitat I. Waernbaum, G. Blohme, J. Ostman et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 49, 653–659 (2006)CrossRefPubMed I. Waernbaum, G. Blohme, J. Ostman et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 49, 653–659 (2006)CrossRefPubMed
20.
Zurück zum Zitat M.I. Constantino, L. Molyneaux, F. Limacher-Gisler et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 36, 3863–3869 (2013)CrossRefPubMedPubMedCentral M.I. Constantino, L. Molyneaux, F. Limacher-Gisler et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 36, 3863–3869 (2013)CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat D.D. Zhang, X. Tang, D.Y. Jin, Y.H. Hu, P. Gao. Prevalence of diabetes in Chinese adults: a meta-analysis. Zhonghua liu xing bing. xue za zhi=Zhonghua liuxingbingxue zazhi 39, 852–857 (2018)PubMed D.D. Zhang, X. Tang, D.Y. Jin, Y.H. Hu, P. Gao. Prevalence of diabetes in Chinese adults: a meta-analysis. Zhonghua liu xing bing. xue za zhi=Zhonghua liuxingbingxue zazhi 39, 852–857 (2018)PubMed
22.
Zurück zum Zitat X. Huo, L. Gao, L. Guo et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 4, 115–124 (2016)CrossRefPubMed X. Huo, L. Gao, L. Guo et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 4, 115–124 (2016)CrossRefPubMed
23.
Zurück zum Zitat O.K. Duru, C.M. Mangione, H.P. Rodriguez et al. Introductory overview of the natural experiments for translation in diabetes 2.0 (NEXT-D2) network: examining the impact of US health policies and practices to prevent diabetes and its complications. Curr. Diab. Rep. 18, 8 (2018)CrossRefPubMedPubMedCentral O.K. Duru, C.M. Mangione, H.P. Rodriguez et al. Introductory overview of the natural experiments for translation in diabetes 2.0 (NEXT-D2) network: examining the impact of US health policies and practices to prevent diabetes and its complications. Curr. Diab. Rep. 18, 8 (2018)CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat E. Jacobs, A. Hoyer, R. Brinks, O. Kuss, W. Rathmann. Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care 40, 1703–1709 (2017)CrossRefPubMed E. Jacobs, A. Hoyer, R. Brinks, O. Kuss, W. Rathmann. Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care 40, 1703–1709 (2017)CrossRefPubMed
25.
Zurück zum Zitat J. Tuomilehto, J. Lindstrom, J.G. Eriksson et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343–1350 (2001)CrossRefPubMed J. Tuomilehto, J. Lindstrom, J.G. Eriksson et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343–1350 (2001)CrossRefPubMed
26.
Zurück zum Zitat G. Li, P. Zhang, J. Wang et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783–1789 (2008)CrossRefPubMed G. Li, P. Zhang, J. Wang et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783–1789 (2008)CrossRefPubMed
27.
Zurück zum Zitat R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, H.A. Neil. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008)CrossRefPubMed R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, H.A. Neil. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008)CrossRefPubMed
Metadaten
Titel
Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study
verfasst von
Yuanchi Hui
Jinping Wang
Yali An
Qiuhong Gong
Hui Li
Bo Zhang
Ying Shuai
Yanyan Chen
Yinghua Hu
Guangwei Li
Publikationsdatum
18.04.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01928-7

Weitere Artikel der Ausgabe 1/2019

Endocrine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.